Vein Homografts Market Development Trends, Competitive Analysis and Key Manufacturers Report 2025

Global Vein Homografts Market: Overview

Vein homografts also known as artery homografts, facilitates the management of problems associated with complex surgeries in otology. Vein homografts are also used for vascular reconstruction in liver transplantation. The vein homografts is shortlisted by the transplant surgeon based on its length. Homografts are mostly used in the reconstruction of segments 5 and 8 veins from right liver graft where patency is required.

View Report-

https://www.transparencymarketresearch.com/vein-homografts-market.html

Global Vein Homografts Market: Drivers and Restraints

Vein homografts are generally used for organ transplants and treatment of otology problems. Increasing number of liver transplants and widespread prevalence of liver diseases and disorders, increasing geriatric population, and prevalence of unmet medical needs in the case of liver cancer are some of the factors likely to drive the growth of the market during the forecast period.

According to American Association for the Study of Liver Diseases, in 2014, the United States performed the most liver transplants in any country at nearly 7,000 per year. The second most active country is China, followed by Brazil with a volume which remarkably exceeds that of any of the European countries. The growth in liver transplants in Brazil has been doubling dramatically within the past seven years. The number of liver transplants performed has increased from 949 in 2005 to 1,756 in 2014.

Global Vein Homografts Market: Key Segments

The vein homografts market is segmented in terms of homograft type, application, end user, and geography. Based on homograft type, the vein homografts market is segmented into saphenous

vein homografts, and cryopreserved cadaveric vein homograft. Based on application, the vein homografts market is segmented into kidney diseases, liver diseases, otology and others. In terms of end user, the vein homografts market is segmented into hospitals, clinics and others.Based on geography, the global vein homografts market is segmented into five regions, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global vein homografts market in 2016. Growing number of liver transplants performed in the U.S. and adoption of technologically advanced products are some of the factors likely to propel growth of vein homografts.

Request Brochure-

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=41093

According to the American Liver Foundation, every year more than 1,500 people die waiting for a donated liver to become available. However, organ transplantation has also been life saving for thousands of people and almost 6,000 liver transplants are performed annually in the U.S. and this number continues to grow. Currently, in the U.S. alone, there are almost 17,000 adults and children who have been approved for liver transplantation and are awaiting the donors to make livers available.Europe is expected to be the second largest market in terms of revenue and the growth in the region can be attributed to treatment advancements, and increasing number of organ transplants in the region. According to a report by European Commission, in 2012, there were 30,685 organ transplants in Europe, of which 19,085 were kidney transplants and 6,973 were liver transplants in the region.

The market in Asia Pacific is expected to register considerable growth during the forecast period, due to development of health care infrastructure, high disposable income, and increasing medical tourism in Asia Pacific countries such as India, Malaysia and others (due to lower cost compared to developed regions such as the U.S. and European countries).

Request For Discount-

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=41093

Global Vein Homografts Market: Key Players

Some of the key players operating in the global vein homografts market include CryoLife, Inc., Medtronic, and Admedus among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website:www.transparencymarketresearch.com

This release was published on openPR.